Stock Report

Download full stock data and analysis for free Last Updated: 15-May-2026

Stock Rating

See the stock’s health at a glance, before it's too late.

Wealth Insight New Issue

Serious stock insights. No fluff. No FOMO.

Recently Viewed

Clear All

Inventiva Sa (IVA)

Stock Card factsheet share-fund-plan-icon

$5.46

up-down-arrow $-0.09 (-1.62%)

As on 15-May-2026 10:36EDT

Market cap

info icon

$1,204 Mln

Revenue (TTM)

info icon

$39 Mln

P/E Ratio

info icon

--

P/B Ratio

info icon

2.1

Div. Yield

info icon

0 %

Inventiva Sa (IVA) Share Price

Compare

High:loading Low:loading Return: loading

Max:loading Min:loading Median:loading

Max:loading Min:loading Median:loading

Price P/E Ratio P/B Ratio

Stock Range

Today’s Range

Low: 5.46 High: 5.66

52 Week Range

Low: 2.85 High: 7.98

Liquidityliquidity Moderate

Low Moderate High

Fundamentals

  • Net Profit (TTM)Net Profit (TTM) information

    $0 Mln

  • ROEROE information

    -16.4 %

  • ROCEROCE information

    -- %

  • Industry P/EIndustry P/E information

    --

  • EV/EBITDAEV/EBITDA information

    -1.3

  • Debt to EquityDebt to Equity information

    -2

  • Book ValueBook Value information

    $--

  • EPSEPS information

    $--

  • Face valueFace value information

    --

  • Shares outstandingShares outstanding information

    207,647,924

10 Years Aggregate

CFO

€-328.01 Mln

EBITDA

€-347.07 Mln

Net Profit

€-350.39 Mln

Performance

Company
YTD
1 Month
3 Months
1 Year
3 Years
5 Years
10 Years
Inventiva Sa (IVA)
17.4 -0.9 -11.5 56.0 26.0 -17.4 --
BSE Sensex
-11.1 -2.1 -8.9 -7.5 6.6 9.1 11.4
S&P Small-Cap 600#
-5.8 -5.3 -13.7 -6.3 5.3 3.0 5.5
As on 15-May-2026  |  #As on 26-Oct-2023
Company
2025
2024
2023
2022
2021
Inventiva Sa (IVA)
117.3 -52.3 1.3 -67.3 -5.8
S&P Small-Cap 600
4.0 7.0 13.9 -17.4 25.3
BSE Sensex
9.1 8.1 18.7 4.4 22.0

Essential Checks

View Details

Is there a threat to the company's solvency?

Can creative accounting be detected through the financial numbers?

How did the company perform in the last one year?

Financials

View Details
Quarterly Annual

*All values are in (€ Mln)

Annual

*All values are in (€ Mln)

Annual

*All values are in (€ Mln)

Key Ratios

View Details

5Y Avg -- 3Y Avg -- TTM --

P/E Ratio

--

--Min --Median --Max

P/B Ratio

--

--Min --Median --Max

Earnings Yield (%)

--

Earnings Yield (%) = EBIT / Enterprise value

PEG Ratio

--

Price = Price / Earnings to growth ratio

Peers

View Details
Company
 Price ($) Market Cap ($ Mln) Revenue (TTM) Net Profit (TTM) OPM (%) ROE (%) P/E P/B
Inventiva Sa (IVA)
5.5 1,204.4 4.5 -340.2 -518.6 501.4 -- 2.1
Fresenius Medical Care AG - ADR
21.7 11,687.9 19,358.7 944.6 9.0 5.5 11.3 0.8
Galapagos NV - ADR
27.5 1,862.3 1,043.8 488.8 -19.0 16 3.2 0.5
Innate Pharma S.A. ADS - ADR
2.1 133.2 2.8 -47.2 -86.4 734.6 -- 20.1
Nanobiotix (NBTX)
49.9 2,596.9 29.6 -24.0 -- 31.9 -- 65.0
Valneva SE - ADR
5.8 597.4 174.7 -115.2 0.0 -80.2 -- 4.3

Shareholding Pattern

View Details
These are advertorial stories which keeps Value Research free for all. Click here to mark your interest for an ad-free experience in a paid plan

About Inventiva Sa (IVA)

Inventiva S.A., a clinical-stage biopharmaceutical company, focuses on the development of oral small molecule therapies for the treatment of metabolic dysfunction-associated steatohepatitis (MASH) and other diseases in France and internationally. It...  develops Lanifibranor, a novel peroxisome proliferator-activated receptor agonist that is in the NATiV3 Phase 3 clinical trial to treat adult patients with MASH; and Odiparcil for the treatment of patients with mucopolysaccharidoses. The company also develops TGF-ß, a pre-clinical program for the treatment of idiopathic pulmonary fibrosis. Inventiva S.A. was incorporated in 2011 and is headquartered in Daix, France. Address: 50 rue de Dijon, Daix, France, 21121  Read more

  • Co-Founder, Chief Scientific Officer, Deputy CEO & Director

    Dr. Pierre Broqua Ph.D.

  • Co-Founder, Chief Scientific Officer, Deputy CEO & Director

    Dr. Pierre Broqua Ph.D.

  • Headquarters

    Daix

  • Website

    https://inventivapharma.com

Value Research Ratings

Our rating system has guided millions of investors in the past 20 years.

Top Rated Stocks

All stocks with 5-star Value Research Ratings

Top Rated Stocks Icon

High Quality Small Caps

Small-cap stocks rated high on quality score

High Quality Small Caps Icon

High Growth Large Caps

Large-cap stocks with a high growth score

High Growth Large Caps Icon

Value Meets Momentum

Top momentum stocks with a high valuation score

Value Meets Momentum Icon

Top Rated Banks

Banks that rate high on Value Research Stock Ratings

Top Rated Banks Icon
Explore Screeners
Edit peer-selector-edit

FAQs for Inventiva Sa (IVA)

The share price of Inventiva Sa (IVA) is $5.46 (NASDAQ) as of 15-May-2026 10:36 EDT. Inventiva Sa (IVA) has given a return of 25.99% in the last 3 years.

Since, TTM earnings of Inventiva Sa (IVA) is negative, P/E ratio is not available.


PE & PB ratio at the end of financial year.


Year P/E Ratio P/B Ratio
2025
--
--
2024
--
--
2023
--
--
2022
--
--
2021
--
--

The 52-week high and low of Inventiva Sa (IVA) are Rs 7.98 and Rs 2.85 as of 15-May-2026.

Inventiva Sa (IVA) has a market capitalisation of $ 1,204 Mln as on 12-May-2026. As per SEBI classification, it is a Small Cap company.

Before investing in Inventiva Sa (IVA), assess your goals, risk tolerance, and if the company aligns with your long-term plan. Carefully review its business model, financials, and valuation. Avoid making decisions based on tips or short-term trends.

For guidance, explore our expert-curated portfolios and Stock recommendations with Value Research Stock Advisor.
Want to explore on your own? Click here to see how this stock scores on quality, growth, valuation, and momentum.